LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Need for Rapid Containment Measures to Drive Growth of Global COVID-19 Detection Kits Market

By LabMedica International staff writers
Posted on 30 May 2020
The growth of the global COVID-19 detection kits market will be driven by the responsiveness of countries to contain the spread of the coronavirus and advancements in healthcare facilities.

These are the latest findings of Transparency Market Research Pvt. Ltd. (Albany, NY, USA), a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. The World Health Organization (WHO) has declared the coronavirus as a global health emergency, following an outbreak of cases in several parts of the world. Currently, more than 180 countries have reported cases of coronavirus among individuals of all age groups. The vulnerability of all groups of people to the virus has created panic among the masses. Therefore, it is important to ramp up manufacturing of COVID-19 detection kits. The value of the COVID-19 detection kits market is continuously rising on account of advancements in healthcare facilities

The healthcare industry has recalibrated its focus on fighting the pandemic. Countries such as Italy, the US, and Spain have been the worst-hit by the pandemic. Therefore, the use of COVID-19 detection kits in these regions has increased by leaps and bounds. As India ramps up its pace of testing, several companies have come to the fore of the healthcare industry. India has also received testing kits from South Korea, which is an important dynamic of market growth. The success of testing facilities in India has been a primary driver of demand within the global market.

Despite strict containment measures such as lockdowns and ban on public gathering, the risk of virus spread remains high. Several healthcare professionals and entities, including the WHO, recommend rapid testing as the foremost strategy to control the virus. Increased number of tests has helped countries in flattening the curve of the COVID-19 spread. Furthermore, testing has also helped governments and state authorities in contact tracing of affected individuals. Thus, the manufacturing of COVID-19 detection kits has assumed significant importance in various parts of the world. The presence of a seamless industry for COVID-19 testing will play a vital role in driving sales across the global market. The development of test kits that can deliver results in less than six hours will play a defining role in the growth of the global COVID-19 detection kits market.

Related Links:
Transparency Market Research Pvt. Ltd.

Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Pipette
Accumax Smart Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more